Synthorx Shares Almost Triple After Sanofi Buyout Offer
09 Décembre 2019 - 4:28PM
Dow Jones News
By Chris Wack
Synthorx Inc. (THOR) shares almost tripled to $68.05 in early
trading after Sanofi SA (SAN.FR) said it was buying the
clinical-stage biotechnology for $68 a share in cash.
The deal has an equity value of about $2.5 billion, and is
expected to close in the first quarter of next year.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
December 09, 2019 10:13 ET (15:13 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Synthorx (NASDAQ:THOR)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Synthorx (NASDAQ:THOR)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Synthorx Inc (NASDAQ): 0 recent articles
Plus d'articles sur Synthorx Inc